Pregnancy outcome following first trimester exposure to sumatriptan.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 9710039.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We prospectively compared pregnancy outcome after exposure to sumatriptan with that of disease-matched controls and nonteratogen controls. There were no differences in the rates of live births, spontaneous abortions, therapeutic abortions, or major birth defects among the three groups. This first prospective report suggests that the use of sumatriptan during organogenesis is not associated with an apparent increased risk of major birth defects.
Medical subject headings
- Pregnancy Outcome
- Serotonin Receptor Agonists
- Sumatriptan